Michel, L. L., Sommer, L., González Silos, R., Lorenzo Bermejo, J., Au, A. v., Seitz, J., . . . Marmé, F. (2019). Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index. PLOS ONE, 14(1), . https://doi.org/10.1371/journal.pone.0211337
Chicago-Zitierstil (17. Ausg.)Michel, Laura L., et al. "Prediction of Local Recurrence Risk After Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer: Clinical Utility of the MD Anderson Prognostic Index." PLOS ONE 14, no. 1 (2019). https://doi.org/10.1371/journal.pone.0211337.
MLA-Zitierstil (9. Ausg.)Michel, Laura L., et al. "Prediction of Local Recurrence Risk After Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer: Clinical Utility of the MD Anderson Prognostic Index." PLOS ONE, vol. 14, no. 1, 2019, https://doi.org/10.1371/journal.pone.0211337.